MYND Life Sciences Inc. (MYND.CN)
CAD 0.07
(-30.0%)
CAD 0.07
(-30.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -198.25 Thousand | -1.81 Million | -2.98 Million | -2778.00 | -708.00 |
| Net Income | -1.51 Million | -3.56 Million | -4.36 Million | -56.46 Thousand | -2535.00 |
| Depreciation & Amortization | 20.98 Thousand | 59.82 Thousand | 86.11 Thousand | - | - |
| Deferred income taxes | 62.54 Thousand | -129.94 Thousand | -168.3 Thousand | - | - |
| Stock-based compensation | 22.87 Thousand | 103.11 Thousand | 1.16 Million | - | - |
| Change in working capital | 1.74 Million | 1.21 Million | -213.02 Thousand | - | - |
| Other non-cash items | -535.99 Thousand | 496.28 Thousand | 517.38 Thousand | 53.68 Thousand | 1827.00 |
| Investing Cash Flow | 198.1 Thousand | -80 Thousand | 2.13 Million | - | - |
| Investments in PPE | -4.00 | - | -149.39 Thousand | - | - |
| Acquisitions | 223.1 Thousand | - | 2.27 Million | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -25 Thousand | -80 Thousand | -105.49 Thousand | - | - |
| Financing Cash Flow | - | - | 2.75 Million | 2778.00 | 708.00 |
| Debt repayment | - | - | -2.64 Million | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 103.75 Thousand | - | - |
| Other Financing Activities | - | - | 5.29 Million | 2778.00 | 708.00 |
| Accounts receivables | 127.39 Thousand | -30.74 Thousand | -97.66 Thousand | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | 1.62 Million | 1.24 Million | -115.36 Thousand | - | - |
| Cash at beginning of period | 412.00 | 1.89 Million | - | - | - |
| Cash at end of period | 257.00 | 412.00 | 1.89 Million | - | - |
| Capital Expenditure | -4.00 | - | -149.39 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -155.00 | -1.89 Million | 1.89 Million | - | - |
| Free Cash Flow | -198.26 Thousand | -1.81 Million | -3.13 Million | -2778.00 | -708.00 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -379.27 Thousand | -259.56 Thousand | -372.76 Thousand | 469.03 Thousand | -1.51 Million | -530.77 Thousand |
| Depreciation & Amortization | 82.00 | 653.00 | 653.00 | 892.00 | 20.98 Thousand | 891.00 |
| Deferred income taxes | - | - | - | -18.92 Thousand | 62.54 Thousand | - |
| Stock-based compensation | - | - | - | 22.87 Thousand | 22.87 Thousand | - |
| Change in working capital | 340.43 Thousand | 222.06 Thousand | 333.78 Thousand | 397.66 Thousand | 1.74 Million | 262.71 Thousand |
| Other non-cash items | 37.5 Thousand | 181.4 Thousand | 1.00 | -1.04 Million | -535.99 Thousand | 216.35 Thousand |
| Investing Cash Flow | -57.00 | 57.00 | - | 223.1 Thousand | 198.1 Thousand | - |
| Investments in PPE | 1306.00 | -1306.00 | - | - | - | - |
| Acquisitions | - | - | - | 223.1 Thousand | 223.1 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -57.00 | 1363.00 | - | 223.10 | -25 Thousand | - |
| Financing Cash Flow | - | - | - | -50 Thousand | - | 50 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -50.00 | - | - |
| Common Stock Issuance | - | - | - | -50 Thousand | - | 50 Thousand |
| Other Financing Activities | - | - | - | - | - | 50.00 |
| Accounts receivables | 16.09 Thousand | -103.42 Thousand | 15.25 Thousand | 5739.00 | 127.39 Thousand | 15.42 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 324.34 Thousand | 325.49 Thousand | 318.53 Thousand | 391.92 Thousand | 1.62 Million | 247.28 Thousand |
| Cash at beginning of period | 1807.00 | 265.00 | 257.00 | 172.00 | 412.00 | 993.00 |
| Cash at end of period | 497.00 | 1807.00 | 265.00 | 257.00 | 257.00 | 172.00 |
| Capital Expenditure | 1306.00 | -1306.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1310.00 | 1542.00 | 8.00 | 85.00 | -155.00 | -821.00 |
| Free Cash Flow | 53.00 | 38.51 Thousand | -38.32 Thousand | -173.01 Thousand | -198.25 Thousand | -50.82 Thousand |
6060
5271
DB
CMFV
PARADEEP
5137